Physician profile
Bryan D Hubbard
NPI 1447305438
$2,489.77
in general payments reported to CMS, 2019-2025
11 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $138 · 2022: $690 · 2023: $459 · 2024: $336 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $672.87 | 2022-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $667.07 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Aroa Biosurgery Incorporated | $298.71 | 2023-2025 | |
| Canon Medical Systems USA, INC. | $200.65 | 2025 | Interventional Angiography System |
| Kci USA, INC. | $155.16 | 2019-2023 | Abthera Advance |
| Integra Lifesciences Corporation | $121.67 | 2022 | |
| Acell, INC. | $115.67 | 2020 | |
| Kls-Martin L.P. | $99.72 | 2019 | |
| Medtronic, INC. | $77.18 | 2023 | Symbotex |
| Stryker Corporation | $58.28 | 2022 | |
| Mallinckrodt Hospital Products INC. | $22.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.